S
Serina Therapeutics, Inc.SER
Serina Therapeutics, Inc. is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina's proprietary POZ Platform technology is designed to optimize the delivery of therapeutic agents and improve their efficacy and safety.
US StocksHealthcareSmall CapBiotechnologyGrowth Stocks
SER の価格トレンド
Serina Therapeutics, Inc. · TradingView フルチャート
NASDAQ:SER